Phenylthiocarbamide (PTC) perception in Parkinson disease

Cognitive and Behavioral Neurology

Volumn 20, Issue 3, 2007, Pages 145-148

  Moberg, Paul J ^a   Balderston, Catherine C ^a   Rick, Jacqueline H ^a   Roalf, David R ^a   Weintraub, Daniel ^a   Kleiner Fisman, Galit ^a   Stern, Matthew B ^a   Duda, John E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Genetics; Parkinson disease; Phenylthiocarbamide; PTC; Taste

Indexed keywords

DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHENYLTHIOUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; HUMAN; MALE; PARKINSON DISEASE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOPHYSICS; RISK FACTOR; TASTE ACUITY; UNITED STATES;

AGED; HUMANS; MALE; PARKINSON DISEASE; PHENYLTHIOUREA; PREVALENCE; TASTE DISORDERS;

EID: 36649016664     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e31812570c3     Document Type: Article

References (33)

1. Reddy BM, Rao DC. Phenylthiocarbamide taste sensitivity revisited: complete sorting test supports residual family resemblance. Genet Epidemiol. 1989;6:413-421.
2. Kim U, Jorgenson E, Coon H, et al. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science. 2003;299:1221-1225.
3. Drayna D, Coon H, Kim UK, et al. Genetic analysis of a complex trait in the Utah Genetic Reference Project: a major locus for PTC taste ability on chromosome 7q and a secondary locus on chromosome 16p. Hum Genet. 2003;112:567-572.
4. Guo SW, Reed DR. The genetics of phenylthiocarbamide perception. Ann Hum Biol. 2001;28:111-142.
5. Yackinous C, Guinard JX. Relation between PROP taster status and fat perception, touch, and olfaction. Physiol Behav. 2001;72:427-437.
6. Emilien G, Maloteaux J-M, Geurts M, et al. Dopamine receptors: physiological understanding to therapeutic intervention potential. Pharmacol Ther. 1999;84:133-156.
7. Gainetdinov RR, Premont RT, Bohn LM, et al. Desensitization of G protein-coupled receptors and functions. Ann Rev Neurosci. 2004;27:107-144.
8. Sidu A, Niznik HB. Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Develop Neurosci. 2000;18:669-677.
9. Pronin AN, Morris AJ, Surguchov A, et al. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J Biol Chem. 2000;24:26515-26522.
10. Tekumalla PK, Calon F, Rahman Z, et al. Elevated levels of delta FosB and RGS9 in striatum in Parkinson's disease. Biol Psychiatry. 2001;50:813-816.
11. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol. 1999;56:33-39.
12. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, et al, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987:153-164.
13. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
14. Driscol KA, Perez M, Cukrowicz KC, et al. Associations of phenylthiocarbamide tasting to alcohol problems and family history of alcoholism differ by gender. Psychiatry Res. 2006;143:21-27.
15. Enoch MA, Harris CR, Goldman D. Does a reduced sensitivity to bitter taste increase the risk of becoming nicotine addicted? Addict Behav. 2001;26:399-404.
16. Joiner T, Perez M. Phenylthiocarbamide tasting and family history of depression, revisited: low rates of depression in families of supertasters. Psychiatry Res. 2004;126:83-87.
17. Whittemore P. Phenylthiocarbamide (PTC) tasting, genetics, and depression. J Clin Psychol. 1990;46:262-272.
18. Sienkiewicz-Jarosz H, Scinska A, Kuran W, et al. Taste responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005;76:40-46.
19. Lang CJG, Leuschner T, Ulrich K, et al. Taste in dementing diseases and Parkinsonism. J Neurol Sci. 2006;248:177-184.
20. Yamauchi Y, Endo S, Yoshimura I. A new whole-mouth gustatory test procedure. II. Effects of aging, gender and smoking. Acta Otolaryngol. 2002;546(suppl):49-59.
21. Muller C, Kallert S, Renner B, et al. Quantitative assessment of gustatory function in a clinical context using impregnated "taste strips" made from filter paper. Rhinology. 2003;41:2-6.
22. Drayna D, Kim U, Wooding S, et al. Genetics of PTC taste sensitivity in humans, in 26th Annual Meeting of the Association for Chemoreception Sciences. Sarasota, FL, 2004:97.
23. Pal SK, Sharma K, Pathak A, et al. Possible relationship between phenylthiocarbamide taste sensitivity and epilepsy. Neurol India. 2004;52:206-209.
24. Constantinidis J. Les marqueurs de chromosomes chez les schizophrènes et la recherche du linkage entre ces caractères et la schizophrenie par la méthode de Penrose. J Genet Hum. 1958;7:189-242.
25. Freire-Maia N, Karam EJ, Mehl H. PTC sensitivity among psychiatric patients. Acta Genet Stat Med. 1968;18:31-37.
26. Moberg PJ, McGue C, Kanes SJ, et al. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance. Schizophrenia Res. 2007;90:221-228.
27. Moberg PJ, Roalf DR, Balderston CC, et al. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree relatives. Am J Psychiatry. 2005;162:788-790.
28. Schlosberg A, Baruch I. Phenylthiocarbamide (PTC) tasting in paranoid and nonparanoid schizophrenic patients. Percept Motor Skills. 1992;74:383-386.
29. Albers MW, Tabert MH, Devanand DP. Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Reports. 2006;6:379-386.
30. Doty RL. Olfaction. Ann Rev Psychol. 2001;52:423-452.
31. Hawkes C. Olfaction in neurodegenerative disorder. Adv Oto-Rhino-Laryngol. 2006;63:133-151.
32. Marras C, Goldman S, Smith A, et al. Smell identification ability in twin pairs discordant for Parkinson's disease. Movement Disord. 2005;20:687-693.
33. Mesholam RI, Moberg PJ, Mahr RN, et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998;55:84-90.